Sandra Pérez‐Torras

888 total citations
29 papers, 680 citations indexed

About

Sandra Pérez‐Torras is a scholar working on Physiology, Oncology and Molecular Biology. According to data from OpenAlex, Sandra Pérez‐Torras has authored 29 papers receiving a total of 680 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Physiology, 11 papers in Oncology and 10 papers in Molecular Biology. Recurrent topics in Sandra Pérez‐Torras's work include Adenosine and Purinergic Signaling (12 papers), Drug Transport and Resistance Mechanisms (6 papers) and Amino Acid Enzymes and Metabolism (4 papers). Sandra Pérez‐Torras is often cited by papers focused on Adenosine and Purinergic Signaling (12 papers), Drug Transport and Resistance Mechanisms (6 papers) and Amino Acid Enzymes and Metabolism (4 papers). Sandra Pérez‐Torras collaborates with scholars based in Spain, United States and Japan. Sandra Pérez‐Torras's co-authors include Marçal Pastor‐Anglada, Adela Mazo, F. Javier Casado, Neus Carbó, Elena Mercadé, Míriam Molina‐Arcas, Laia Trigueros‐Motos, José Manuel García-Manteiga, A. Mazo and Marta Llopis and has published in prestigious journals such as International Journal of Molecular Sciences, Cellular and Molecular Life Sciences and Biochemical Pharmacology.

In The Last Decade

Sandra Pérez‐Torras

29 papers receiving 673 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandra Pérez‐Torras Spain 13 299 232 231 85 76 29 680
Ilona Born Germany 12 245 0.8× 513 2.2× 61 0.3× 62 0.7× 93 1.2× 23 713
Pietro Pozzi Italy 10 762 2.5× 263 1.1× 64 0.3× 111 1.3× 53 0.7× 13 1.1k
Rebecca Gupte United States 8 517 1.7× 559 2.4× 113 0.5× 95 1.1× 87 1.1× 9 1.0k
Franciele Kipper United States 12 214 0.7× 89 0.4× 65 0.3× 77 0.9× 61 0.8× 20 437
James W.A. Ritchie United Kingdom 10 848 2.8× 317 1.4× 36 0.2× 107 1.3× 44 0.6× 11 1.2k
Pál I. Bauer Hungary 17 494 1.7× 334 1.4× 57 0.2× 70 0.8× 56 0.7× 33 729
John Armstrong United States 11 226 0.8× 104 0.4× 130 0.6× 139 1.6× 70 0.9× 19 820
Andreas Noack Germany 14 321 1.1× 257 1.1× 22 0.1× 124 1.5× 47 0.6× 17 719
Fábio V. Fonseca United States 12 279 0.9× 40 0.2× 73 0.3× 54 0.6× 91 1.2× 18 715
Matheus Dyczynski Sweden 7 554 1.9× 111 0.5× 55 0.2× 235 2.8× 446 5.9× 8 928

Countries citing papers authored by Sandra Pérez‐Torras

Since Specialization
Citations

This map shows the geographic impact of Sandra Pérez‐Torras's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Pérez‐Torras with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Pérez‐Torras more than expected).

Fields of papers citing papers by Sandra Pérez‐Torras

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Pérez‐Torras. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Pérez‐Torras. The network helps show where Sandra Pérez‐Torras may publish in the future.

Co-authorship network of co-authors of Sandra Pérez‐Torras

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Pérez‐Torras. A scholar is included among the top collaborators of Sandra Pérez‐Torras based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Pérez‐Torras. Sandra Pérez‐Torras is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Izquierdo, E., et al.. (2024). RNase H-sensitive multifunctional ASO-based constructs as promising tools for the treatment of multifactorial complex pathologies. Bioorganic Chemistry. 150. 107595–107595. 4 indexed citations
2.
Marín, Silvia, Pedro de Atauri, Estefanía Moreno, et al.. (2022). An Escape-Room about Krebs cycle prepared for Chemical Students. Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona). 3(2). 155–164. 1 indexed citations
3.
Martín‐Satué, Mireia, et al.. (2021). OncomiRs miR-106a and miR-17 negatively regulate the nucleoside-derived drug transporter hCNT1. Cellular and Molecular Life Sciences. 78(23). 7505–7518. 4 indexed citations
4.
Pérez‐Torras, Sandra, Britt I. Drögemöller, Maja Tarailo‐Graovac, et al.. (2019). Deficiency of perforin and hCNT1, a novel inborn error of pyrimidine metabolism, associated with a rapidly developing lethal phenotype due to multi-organ failure. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1865(6). 1182–1191. 6 indexed citations
5.
Català, Albert, et al.. (2019). FMS-like tyrosine kinase 3 (FLT3) modulates key enzymes of nucleotide metabolism implicated in cytarabine responsiveness in pediatric acute leukemia. Pharmacological Research. 151. 104556–104556. 4 indexed citations
6.
Pastor‐Anglada, Marçal & Sandra Pérez‐Torras. (2018). Emerging Roles of Nucleoside Transporters. Frontiers in Pharmacology. 9. 606–606. 113 indexed citations
7.
Pastor‐Anglada, Marçal, et al.. (2018). Intestinal Nucleoside Transporters: Function, Expression, and Regulation. Comprehensive physiology. 8(3). 1003–1017. 37 indexed citations
8.
Pastor‐Anglada, Marçal & Sandra Pérez‐Torras. (2018). Who Is Who in Adenosine Transport. Frontiers in Pharmacology. 9. 627–627. 99 indexed citations
9.
Pastor‐Anglada, Marçal, et al.. (2018). Intestinal Nucleoside Transporters: Function, Expression, and Regulation. Comprehensive physiology. 8(3). 1003–1017. 3 indexed citations
10.
Pérez‐Torras, Sandra, Marta Llopis, Juan José Lozano, et al.. (2016). Transportome Profiling Identifies Profound Alterations in Crohn’s Disease Partially Restored by Commensal Bacteria. Journal of Crohn s and Colitis. 10(7). 850–859. 26 indexed citations
11.
Pérez‐Torras, Sandra, Juan José Lozano, Marta R. Romero, et al.. (2016). Pharmacogenomic analyzis of the responsiveness of gastrointestinal tumor cell lines to drug therapy: A transportome approach. Pharmacological Research. 113(Pt A). 364–375. 4 indexed citations
12.
Minami, Kentaro, Yoshinari Shinsato, Masatatsu Yamamoto, et al.. (2015). Ribonucleotide reductase is an effective target to overcome gemcitabine resistance in gemcitabine-resistant pancreatic cancer cells with dual resistant factors. Journal of Pharmacological Sciences. 127(3). 319–325. 47 indexed citations
13.
Pérez‐Torras, Sandra, et al.. (2015). Human pancreatic cancer stem cells are sensitive to dual inhibition of IGF-IR and ErbB receptors. BMC Cancer. 15(1). 223–223. 17 indexed citations
14.
Pérez‐Torras, Sandra, et al.. (2013). Concentrative nucleoside transporter 1 (hCNT1) promotes phenotypic changes relevant to tumor biology in a translocation-independent manner. Cell Death and Disease. 4(5). e648–e648. 23 indexed citations
15.
Errasti‐Murugarren, Ekaitz, Paula Fernández‐Calotti, Sandra Pérez‐Torras, et al.. (2012). Role of the Transporter Regulator Protein (RS1) in the Modulation of Concentrative Nucleoside Transporters (CNTs) in Epithelia. Molecular Pharmacology. 82(1). 59–67. 11 indexed citations
16.
Pérez‐Torras, Sandra, Meritxell Carrió, Anna Cascante, et al.. (2011). Connexin-26 Is a Key Factor Mediating Gemcitabine Bystander Effect. Molecular Cancer Therapeutics. 10(3). 505–517. 30 indexed citations
17.
Guillén‐Gómez, Elena, Sandra Pérez‐Torras, Doo‐Sup Choi, et al.. (2011). New role of the human equilibrative nucleoside transporter 1 (hENT1) in Epithelial‐to‐mesenchymal transition in renal tubular cells. Journal of Cellular Physiology. 227(4). 1521–1528. 18 indexed citations
18.
Pérez‐Torras, Sandra, Rosa Miquel, Vanessa Almendro, et al.. (2011). Characterization of human pancreatic orthotopic tumor xenografts suitable for drug screening. Cellular Oncology. 34(6). 511–521. 20 indexed citations
19.
Pérez‐Torras, Sandra, José Manuel García-Manteiga, Elena Mercadé, et al.. (2008). Adenoviral-mediated overexpression of human equilibrative nucleoside transporter 1 (hENT1) enhances gemcitabine response in human pancreatic cancer. Biochemical Pharmacology. 76(3). 322–329. 40 indexed citations
20.
Peñuelas, Silvia, Manel Cascalló, José Luís Hernández, et al.. (2004). Expression Profiles of a Human Pancreatic Cancer Cell Line upon Induction of Apoptosis Search for Modulators in Cancer Therapy. Oncology. 67(3-4). 277–290. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ilona Born Breakdown of academic impact, for papers by Pietro Pozzi Breakdown of academic impact, for papers by Rebecca Gupte Breakdown of academic impact, for papers by Franciele Kipper Breakdown of academic impact, for papers by James W.A. Ritchie Breakdown of academic impact, for papers by Pál I. Bauer Breakdown of academic impact, for papers by John Armstrong Breakdown of academic impact, for papers by Andreas Noack Breakdown of academic impact, for papers by Fábio V. Fonseca Breakdown of academic impact, for papers by Matheus Dyczynski
Rankless by CCL
2026